Health NLRP3 Inflammasome: Potential New Target for MS Treatments – Study by Dr Natalie Singh - Health Editor February 20, 2026 by Dr Natalie Singh - Health Editor February 20, 2026 Key Immune Trigger Identified in Multiple Sclerosis Progression Researchers at Trinity College Dublin have identified a key immune system switch, the NLRP3 inflammasome, that may play a significant role in … 0 FacebookTwitterPinterestEmail